Target intelligence / Profile preview

5'-AMP-activated protein kinase catalytic subunit alpha mRNA 3'-untranslated region (AMPKα mRNA 3'-UTR)

Target
AMPKα mRNA 3'-UTR
Molecular classification
RNA, Messenger RNA regulatory region
01

Overview

The 3'-untranslated region (3'-UTR) of the AMPKα mRNA is a critical regulatory segment that controls the expression of the catalytic alpha subunit of AMP-activated protein kinase (AMPK). AMPK serves as a master regulator of cellular energy homeostasis, activating catabolic pathways to generate ATP while inhibiting anabolic processes during energy stress (Hardie et al., 2012, Genes & Development). The 3'-UTR contains specific binding sites for microRNAs, such as miR-33 and miR-451, which post-transcriptionally repress AMPK expression by inducing mRNA degradation or inhibiting translation (Davalos et al., 2011, Nature; Godlewski et al., 2010, Cancer Research). In metabolic diseases like obesity and type 2 diabetes, the overexpression of certain microRNAs can lead to pathologically low levels of AMPK, exacerbating insulin resistance and lipid accumulation. Consequently, the AMPKα mRNA 3'-UTR is an emerging therapeutic target for RNA-based interventions, including antisense oligonucleotides and microRNA modulators, designed to restore AMPK activity. Beyond metabolism, this regulatory region is also studied in oncology, where AMPK acts as a metabolic tumor suppressor that can be silenced by microRNAs in the tumor microenvironment.

Other names
PRKAA1 mRNA 3'-UTRPRKAA2 mRNA 3'-UTR3'-untranslated region of AMPK alphaAMP-activated protein kinase alpha subunit mRNA 3'-UTRAMPK alpha 3'-UTR
02

Mechanism of action

Modulation of AMPK protein expression through the regulation of mRNA stability or translation efficiency, often by blocking or mimicking microRNA binding to the 3'-UTR to either increase or decrease AMPK levels.

03

Biological functions

Regulation of mRNA stabilityTranslation regulationEnergy homeostasisMetabolic regulation
04

Disease associations

Type 2 diabetesObesityMetabolic syndromeCancerNon-alcoholic fatty liver disease (NAFLD)
05

Safety considerations

Off-target effects of RNA-targeting therapiesPotential for systemic metabolic imbalance due to ubiquitous AMPK expressionTissue-specific delivery challengesPotential for unintended gene silencing
06

Interacting drugs

miR-33 inhibitors (Antagomirs)

3 more in the full profile.

07

Biomarkers

AMPK alpha protein levelsPhosphorylated AMPK (p-AMPK)Blood glucose levelsCirculating lipid levelsmiR-33 expression levels

Beyond the preview

Go deeper on 5'-AMP-activated protein kinase catalytic subunit alpha mRNA 3'-untranslated region (AMPKα mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-AMP-activated protein kinase catalytic subunit alpha mRNA 3'-untranslated region (AMPKα mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call